| Literature DB >> 30224989 |
Kristina Aluzaite1, Jordan Tewhaiti-Smith1, Margaret Fraser2, Steve Johnson1,2, Elizabeth Glen2, Allison Beck3, Barbara Smith4, Jack Dummer1, Michael Schultz1,2.
Abstract
Hepatitis C virus (HCV) and B virus (HBV) infections are highly prevalent, with a high percentage of undiagnosed cases. Knowledge of HCV and its modes of transmission are essential for disease prevention and management. We studied a high-risk New Zealand gang population on viral hepatitis prevalence, their level of knowledge and the liver health risk factors in a community setting. Participants completed demographic, risk factor and knowledge questionnaires in three health meetings in New Zealand. Participants' blood samples were tested for HBV, HCV, biochemical indicators of liver disease. Liver fibrosis levels were assessed using a Fibroscan® device. We studied 52 adult Mongrel Mob members, affiliates and whānau (extended family) throughout New Zealand. We identified no HCV and two HBV cases, confirmed high-risk factor levels and poor associated knowledge, with a significant association between lack of knowledge and presence of specific risk factors. We successfully conducted a community-focused, high-risk, hard-to-reach gang population study, and found a link between lack of knowledge and risk factors for HCV infection. This study provided first-of-its-kind data on viral hepatitis in a gang population and demonstrated the need for educational screening programmes to aid early HCV detection, prevention and treatment.Entities:
Keywords: New Zealand; gang population; hepatitis B; hepatitis C; liver health
Year: 2018 PMID: 30224989 PMCID: PMC6124044 DOI: 10.1098/rsos.172167
Source DB: PubMed Journal: R Soc Open Sci ISSN: 2054-5703 Impact factor: 2.963
Characteristics of the study population.
| participant characteristics | % ( |
|---|---|
| type of participant | |
| gang member | 34.6% ( |
| affiliate | 9.6% ( |
| extended family/Whānau | 55.8% ( |
| sex, male | 51.9% ( |
| age (years), median (IQR) | 36.0 (27.5–43.0) |
| study location | |
| Dunedin | 25% ( |
| Wellington | 36.5% ( |
| Turangi | 38.5% ( |
| ethnicity | |
| Māori | 75% ( |
| education | |
| below secondary | 19.6% ( |
| secondary | 47.1% ( |
| tertiary | 11.8% ( |
| undergraduate | 5.9% ( |
| graduate | 15.7% ( |
| regular GPa visits | |
| weekly–monthly | 17.6% ( |
| 6 monthly | 37.3% ( |
| yearly | 9.8% ( |
| 5 yearly/rarely | 35.3% ( |
| perceived BMI | |
| underweight | 5.9% ( |
| normal weight | 35.3% ( |
| overweight | 54.9% ( |
| excessively overweight | 3.9% ( |
| BMI (Turangi cohort) | ( |
| overall median (IQR) | 32.9 (28.7–36.1) |
| normal (BMI = 24) | 5% ( |
| overweight (25.0–29.9) | 25% ( |
| obesity class I (30.0–34.9) | 40% ( |
| obesity class II and III (greater than 35.0) | 30% ( |
aGeneral practitioner.
Figure 1.Risk factor prevalence comparison between the combined gang member and affiliate, and whānau (extended family) groups.
Figure 2.Alcohol consumption patterns in the study population—consumption frequency and quantity of standard drinks per session.
Hepatitis C virus-associated knowledge questionnaire response summary.
| question | % correct answers ( |
|---|---|
| 1. How hepatitis B and C are spread/transmitted? | |
| sharing a toothbrush or razor with an infected person | 65% ( |
| sharing needles, spoons, filters (IV drug utensils) | 86% ( |
| through sexual intercourse | 63% ( |
| from mother to baby at birth | 55% ( |
| unsterile medical/dental/cosmetic procedures (tattoos/piercings) | 51% ( |
| contact sport/fighting | 41% ( |
| occupational hazards (exposure to blood in the work place) | 59% ( |
| 2. Can a hepatitis infection be treated? | |
| hepatitis B | 60% ( |
| hepatitis C | 57% ( |
| 3. Is treatment for hepatitis funded in New Zealand? | 20% ( |
| 4. Who would you approach to get treatment? | |
| GP | 80% ( |
| gastroenterologist | 4% ( |
| infectious disease specialist | 20% ( |
| 5. How common do you think viral hepatitis is in New Zealand? | 50–39% ( |
| 20–31% ( | |
| 10–16% ( | |
| 5–2% ( | |
| 1–2% ( | |
| 6. Can you be vaccinated against: | |
| hepatitis B (‘yes’; ‘don't know’) | 39% ( |
| hepatitis C (‘no’; ‘don't know’) | 10% ( |
| 7. What are the possible long-term problems associated with hepatitis? | |
| liver cancer | 47% ( |
| liver cirrhosis/scarring | 43% ( |
| liver failure | 63% ( |
| no long-term problems | 18% ( |
| 8. Symptoms of hepatitis B/C infection can include | 29–43% correctly identified different symptoms |
| 9. How long does it take for symptoms of a chronic infection to be noticed? | never—11% ( |
| days—21% ( | |
| weeks—15% ( | |
| months—30% ( | |
| years—28% ( |
Figure 3.Differences in the overall hepatitis knowledge questionnaire scores based on (a) gang affiliation; (b) gender; (c) participants' age; presented with 95% confidence intervals.